Back to Top Skip to main content
Alert Arrow ALERT!!

There are emergency procedures in place for parts of world due to weather.

Get the latest information on emergency prescription refills and PCM referral waivers. 

2017 Meetings

November 15-16, 2017

Uniform Formulary Request for Quote Information
  • UF BPA & UF ADP RFQ Documents Posted: August 21, 2017
  • Pre-Proposal Teleconference: September 7, 2017 @ 1200 Central 
  • Clinical/Cost Presentation Meeting Window: August - September, 2017
  • UF BPA & UF ADP Quotes Due: October 13, 2017 
  • P&T Committee Meeting: November 15-16, 2017
Class Review  Designated Newly Approved Drugs Drugs in Previously Reviewed Classes
  • Weight Loss Agents: Belviq, Belviq XR, Contrave, Qsymia, Saxenda, Xenical
  • Oncological Agents - Multiple Myeloma: Alkeran, Farydak, Melphalan, Ninlaro, Pomalyst, Revlimid, Thalomid
  • ArmonAir RespiClick
  • Baxdela
  • Benlysta
  • Bevyxxa
  • Cotempla XR ODT
  • Duzallo
  • Endari
  • Fiasp
  • Flolipid
  • Fycompa O/S
  • Gocovri
  • Haegarda
  • Idhifa
  • Mavyret
  • Nerlynx
  • Nityr
  • Symproic
  • Trelegy Ellipta
  • Tremfya
  • Verzenio
  • Vosevi


August 9-10, 2017

Uniform Formulary Request for Quote Information
  • UF BPA & UF ADP RFQ Documents Posted: May 5, 2017
  • Pre-Proposal Teleconference: May 18, 2017 @ 1200 Central 
  • Clinical/Cost Presentation Meeting Window: May - June, 2017
  • UF BPA & UF ADP Quotes Due: June 30, 2017 
  • P&T Committee Meeting: August 9-10, 2017
Class Review  Designated Newly Approved Drugs Drugs in Previously Reviewed Classes
  • Antiretrovirals - Combinations: Atripla, Complera, Genvoya, Odefsey, Stribild, Triumeq
  • Antiretrovirals - Integrase Strand Transfer Inhibitors (INSTIs): Isentress, Tivicay, Vitekta
  • Antiretrovirals - Nucleoside/Nucleotide Reverse Transcriptase Inhibitor (NRTIs): Descovy, Emtriva, Trizivir, Truvada, Viread, Ziagen
  • Antiretrovirals - Other Agents: Aptivus, Crixivan, Edurant, Evotaz, Intelence, Invirase, Kaletra, Lexiva, Norvir, Prezcobix, Prezista, Rescriptor, Selzentry, Tybost, Viracept
  • Corticosteroids/Immune Modulators - Hereditary Angioedema Agents: Berinert, Cinryze, Firazyr, Kalbitor, Ruconest
  • Insulins - Basal: Basaglar Kwikpen U-100, Lantus, Lantus Solostar, Levemir, Levemir Flexpen, Levemir Flextouch, Toujeo Solostar, Tresiba Flextouch U-100, Tresiba Flextouch U-200
  • AirDuo RespiClick
  • Alunbrig
  • Ingrezza
  • Intrarosa
  • Jadenu Sprinkle
  • Kevzara
  • Kisqali Femara Co-Pack
  • Morphabond ER
  • Mydayis ER
  • Rydapt
  • Siliq
  • Syndros
  • Tymlos
  • Xadago
  • Xatmep
  • Zejula


May 10-11, 2017

Uniform Formulary Request for Quote Information
  • UF BPA & UF ADP RFQ Documents Posted: February 15, 2017
  • Pre-Proposal Teleconference: February 21, 2017 @ 1400 Central 
  • Clinical/Cost Presentation Meeting Window: March - April, 2017
  • UF BPA & UF ADP Quotes Due: April 3, 2017 
  • P&T Committee Meeting: May 10-11, 2017
Class Review  Designated Newly Approved Drugs Drugs in Previously Reviewed Classes 
  • Overactive Bladder Agents: Gelnique, Myrbetriq, Oxytrol, Toviaz, Vesicare - Solicitation Cancelled
  • Ophthalmic-1 Agents: Bepreve, Emadine, Lastacaft, Pataday, Pazeo
  • Pulmonary Miscellaneous:  Esbriet, Ofev   
  • Arymo ER
  • Austedo
  • Dupixent
  • Emflaza
  • Eucrisa
  • Kisqali
  • Rhofade
  • Trulance
  • Xermelo
  • Xultophy


February 8-9, 2017

Class Review  Designated Newly Approved Drugs Drugs in Previously Reviewed Classes 
  • Antibiotics - Tetracyclines
  • Hepatitis C Agents - Direct Acting Agents
  • Ophthalmic-1 Agents - Antihistamine Mast Cell Stabilizers: Solictation Cancelled
  • Adlyxin
  • Basaglar
  • BromSite
  • Rayaldee
  • Rubraca
  • Soliqua
  • Vemlidy

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing: Download a PDF Reader or learn more about PDFs.